Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Haleh Nadim"'
Autor:
Ahmad El-Hellani, Elyana Hanna, Mehak Sharma, Reagan Blohowiak, Phillip Joseph, Tore Eid, Haleh Nadim, Rachel El-Hage, Rola Salman, Nareg Karaoghlanian, Ayomipo Adeniji, Sally Salam, Farid Talih, Martine Elbejjani, Alison Breland, Thomas Eissenberg, Alan Shihadeh, Stephen R Baldassarri, Soha Talih
Publikováno v:
PLoS ONE, Vol 18, Iss 9, p e0291786 (2023)
IntroductionElectronic cigarette (EC) use has increased rapidly in the last decade, especially among youth. Regulating nicotine delivery from ECs could help curb youth uptake and leverage EC use in harm reduction yet is complicated by varying device
Externí odkaz:
https://doaj.org/article/2e29af902b17427288ee1aa7bb77ae8c
Publikováno v:
Alcohol
Background Acute alcohol consumption triggers release of cytokines, which are immune signaling molecules. Dysregulated cytokine levels are associated with impaired immune function, and peripheral cytokine levels may communicate with the brain to prop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f3e18898e390e352a98683a46fe4fea
https://europepmc.org/articles/PMC7739954/
https://europepmc.org/articles/PMC7739954/
Autor:
Haleh Nadim, Peter Jatlow, Ralitza Gueorguieva, Mehmet Sofuoglu, Gerald W. Valentine, Marcedes Coffman
Publikováno v:
Drug and Alcohol Dependence. 159:272-276
Background The liquids (e-liquids) used in an electronic cigarette (e-cigarette) contain myriad chemicals without adequate human inhalation safety data. Furthermore, the absence of e-liquid labeling requirements poses a formidable challenge to unders
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ffbd93b51b5c26c14008c91dd7d0945
https://doi.org/10.1016/j.drugalcdep.2015.12.011
https://doi.org/10.1016/j.drugalcdep.2015.12.011
Autor:
Julia M. Shi, James Dziura, Stephanie S. O'Malley, Elizabeth Ralevski, Peter Jatlow, Ismene L. Petrakis, Christine Nogueira, Ann Agro, Benjamin A. Toll, Ran Wu, Haleh Nadim
Publikováno v:
Alcoholism: Clinical and Experimental Research. 38:2056-2065
The ethanol metabolites, ethyl glucuronide (EtG) and ethyl sulfate (EtS), are biomarkers of recent alcohol consumption that provide objective measures of abstinence. Our goals are to better understand the impact of cutoff concentration on test interp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58c81038c135d2fc29273129cc917005
https://doi.org/10.1111/acer.12407
https://doi.org/10.1111/acer.12407
Autor:
Jason I. Chen, P. Jatlow, Jane Wanyiri, Haleh Nadim, David Matuskey, Marc N. Potenza, Brian Pittman, Rt T. Malison, Pt T. Morgan, Zubin Bhagwagar, Ralitza Gueorguieva
Publikováno v:
Pharmacology Biochemistry and Behavior. 103:95-101
Prior work by our group has shown the feasibility, safety, and validity of a multi-day, multi-dose paradigm of self-regulated cocaine administration in humans. The current work sought to consolidate these methods in a single-day design focused on red
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a411ca61c92ca4cb6ee3d324f95a527
https://doi.org/10.1016/j.pbb.2012.08.009
https://doi.org/10.1016/j.pbb.2012.08.009
Publikováno v:
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 37(6)
The ratio of nicotine metabolites (trans-3′-hydroxycotinine (3HC) to cotinine) correlates with nicotine clearance. In previous studies, high nicotine metabolite ratio (NMR) predicted poor outcomes for smoking cessation treatment with nicotine patch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a125a1453e8d514419dc9c91e826a73
https://pubmed.ncbi.nlm.nih.gov/22334123
https://pubmed.ncbi.nlm.nih.gov/22334123
Autor:
Mohini Ranganathan, Nagendra M. Singh, Peter Jatlow, Raymond F. Suckow, Jacqueline Elander, Haleh Nadim, Brian Pittman, Kyung-Heup Ahn, Deepak Cyril D'Souza, Savita G. Bhakta
Publikováno v:
Biological psychiatry. 72(9)
Background The uncompetitive N -methyl-D-aspartate receptor (NMDAR) antagonist, ketamine, induces a range of symptoms resembling those seen in schizophrenia. Enhancement of nicotinic acetylcholine receptor (nAChR) function may have potential as a tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e82566efe78fab5f2f0a5cd61fc26d8
https://pubmed.ncbi.nlm.nih.gov/22717030
https://pubmed.ncbi.nlm.nih.gov/22717030